-
The first graph looks at what happened to cases of invasive pneumococcal disease when the vaccine was introduced.
FORBES: A Vaccine Eliminated A Deadly Killer Of Infants. So Why Do Some People Fear It?
-
The graphs below paint a clear picture of how the rise of 19A is overwhelmingly outweighed by the decrease in pneumococcal disease.
FORBES: A Vaccine Eliminated A Deadly Killer Of Infants. So Why Do Some People Fear It?
-
There, 83, 000 patients have been randomized to receive either Prevnar 13 or placebo to see if the vaccine prevents cases of pneumococcal disease.
FORBES: Pfizer's Vaccine Plan
-
Pneumococcal disease is a substantial cause of illness and death.
FORBES: The Government Is Dragging Its Feet on New Vaccines
-
Some 50, 000 Americans die annually from pneumococcal disease.
FORBES: Pfizer's Vaccine Plan
-
There is promise there, particularly in the lung cancer drug crizotinib, which is being submitted to the Food and Drug Administration, and to Prevnar, the vaccine against pneumococcal disease, which is being tested in adults.
FORBES: Why Pfizer Will Break Up
-
In fact, one paper Mercola cites, which noted a 71% increase in the prevalence of 19A, also said there had been a dramatic 44% reduction in invasive pneumococcal disease, including pneumonia, meningitis, and bloodstream infections and that includes the increase in 19A. The new vaccine, Prevnar 13, introduced in 2010, protects against the deadly 19A strain, which now appears to be on the wane.
FORBES: A Vaccine Eliminated A Deadly Killer Of Infants. So Why Do Some People Fear It?
-
Today such strains show up in the U.S., and current pneumococcal vaccines may not stop them, says Jacobs, now an infectious-disease specialist at Case Western Reserve University.
FORBES: Germ Warfare
-
In the US, where an individual pneumococcal vaccine is given to children during the first 18 months, there has been a two thirds fall in the disease.
BBC: NEWS | Health | Combined jab 'not as effective'